This is the centennial year for the Scopes “monkey trial” in Dayton, Tennessee, 1925’s “trial of the century”. In the dock was John Scopes, a substitute high school teacher who was accused of ...

Scancell Holdings plc (AIM: SCLP), the developer of active immunotherapies to treat cancer, announces updated positive data from the SCOPE Phase 2 trial of iSCIB1+ in combination with ipilimumab and ...

NOTTINGHAM, United Kingdom, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP), the developer of active immunotherapies to treat cancer, announces updated positive data from the SCOPE ...

Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+ in patients with first line advanced melanoma Progression free survival (PFS) of 74% at 16 months ...

In July 1925, John Thomas Scopes, a Tennessee high school teacher, was tried for teaching that man descended from a lower order of animals, in violation ...

The drivers of these changes are primarily movements in valuations of the two principal AIM quoted investments – Scancell Holdings Plc (“Scancell) and Arecor Therapeutics Plc (“Arecor”). The three ...